Department of General, Visceral, Vascular and Pediatric Surgery, University Hospital Würzburg, Oberduerrbacherstrasse 6, 97080, Wuerzburg, Germany.
Department for Diabetology and Endocrinology, Clinic for Internal Medicine I, University Hospital Wuerzburg, Oberduerrbacherstrasse 6, 97080, Wuerzburg, Germany.
Langenbecks Arch Surg. 2021 Aug;406(5):1615-1624. doi: 10.1007/s00423-021-02191-z. Epub 2021 May 16.
Repeat surgery in patients with primary hyperparathyroidism (pHPT) is associated with an increased risk of complications and failure. This stresses the need for optimized strategies to accurately localize a parathyroid adenoma before repeat surgery is performed. However, evidence on the extent of required diagnostics for a structured approach is sparse.
A retrospective single-center evaluation of 28 patients with an indication for surgery due to pHPT and previous thyroid or parathyroid surgery was performed. Diagnostic workup, surgical approach, and outcome in terms of complications and successful removement of parathyroid adenoma with biochemical cure were evaluated.
Neck ultrasound, sestamibi scintigraphy, C11-methionine PET-CT, and selective parathyroid hormone venous sampling, but not MRI imaging, effectively detected the presence of a parathyroid adenoma with high positive predictive values. Biochemical cure was revealed by normalization of calcium and parathormone levels 24-48h after surgery and was achieved in 26/28 patients (92.9%) with an overall low rate of complications. Concordant localization by at least two diagnostic modalities enabled focused surgery with success rates of 100%, whereas inconclusive localization significantly increased the rate of bilateral explorations and significantly reduced the rate of biochemical cure to 80%.
These findings suggest that two concordant diagnostic modalities are sufficient to accurately localize parathyroid adenoma before repeat surgery for pHPT. In cases of poor localization, extended diagnostic procedures are warranted to enhance surgical success rates. We suggest an algorithm for better orientation when repeat surgery is intended in patients with pHPT.
甲状旁腺功能亢进症(pHPT)患者的再次手术与并发症和手术失败的风险增加相关。这强调了需要优化策略,以便在进行重复手术之前准确定位甲状旁腺腺瘤。然而,关于结构化方法所需诊断的证据很少。
对 28 例因 pHPT 和先前甲状腺或甲状旁腺手术而有手术指征的患者进行了回顾性单中心评估。评估了诊断工作、手术方法以及并发症和成功切除甲状旁腺腺瘤的生化治愈情况。
颈部超声、锝 99m 甲氧基异丁基异腈闪烁扫描、C11-蛋氨酸正电子发射断层扫描和选择性甲状旁腺激素静脉取样,但不是 MRI 成像,有效地检测到甲状旁腺腺瘤的存在,具有较高的阳性预测值。生化治愈通过术后 24-48 小时钙和甲状旁腺激素水平的正常化来揭示,并在 28 例患者中的 26 例(92.9%)中实现,总并发症发生率较低。至少两种诊断方法的一致定位使手术成功率达到 100%,而不确定的定位显著增加了双侧探查的发生率,并显著降低了生化治愈率至 80%。
这些发现表明,在 pHPT 的重复手术之前,两种一致的诊断方法足以准确地定位甲状旁腺腺瘤。在定位不佳的情况下,需要扩展诊断程序以提高手术成功率。我们建议在 pHPT 患者中进行重复手术时提供更好的指导算法。